Buy these 2 impressive ASX shares in May 2022: experts

These two ASX shares are both growing and could be impressive investments, according to experts.

| More on:
A woman sits at her computer in deep contemplation with her hand to her chin and seriously considering information she is receiving from the screen of her laptop regarding the Xero share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Both of these ASX shares have captured a large part of their respective markets
  • REA Group is Australia’s largest real estate portal business
  • Volpara is an ASX healthcare share that specialises in breast screening

Experts currently have a very favourable opinion about some impressive ASX shares. May 2022 could be the month to jump on some of these stocks.

Businesses that are growing revenue and profit at a double-digit rate could be opportunities after their recent declines.

Here are two such buy-rated ASX shares:

REA Group Limited (ASX: REA)

REA Group claims to be the leading property portal business in Australia with realestate.com.au.

It also has several other property-related digital assets including realcommercial and flatmates as well as investments in a number of international sites in Asia and the US.

Since the start of 2022, the REA Group share price has fallen almost 25%.

The ASX share has been growing profit and is seeing a recovery in listing volumes. In the FY22 first half, the company reported an “exceptional” performance. Core operations saw revenue growth of 37% to $590 million and net profit after tax (NPAT) growth of 31% to $226 million.

Its US investment Move Inc saw revenue growth of 19%, while REA India revenue growth was 125%.

In the first half of FY22, national residential listings were up 17%. January 2022 saw national residential listings rise another 14% year on year.

REA Group is rated as a buy by the broker Morgan Stanley, with a price target of $178. That’s an upside of around 40%.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a ASX healthcare technology share. It provides software for breast screening as well as administration tools for clinics.

The Volpara share price has fallen almost 20% in 2022.

The company has built up a market position in the US with coverage of 35.5% of women being screened at 31 March 2022.

This ASX share generates a large amount of its revenue from subscriptions through a software as a service (SaaS) model. Annual recurring revenue (ARR) is now around NZ$31.8 million. The quarter for the three months to 31 March 2022 showed subscription revenue growth of 39% to NZ$7.5 million, with SaaS client churn remaining “low”.

While the company has a leading position in the US, it is expanding in other regions with contracts. It has signed a distribution deal with IMS Giotto in Italy. Multiple orders are in place, with the possibility of up to 100.

It has also signed its first deal in the Middle East with Cleveland Clinic Abu Dhabi, which was recently named the top hospital in the UAE.

The company has a very high gross profit margin. In the FY22 first half, its gross margin was 91.4%.

Volpara is working on growing its average revenue per user (ARPU) by selling more modules to clients. It is also working on its lung cancer screening opportunity.

It’s rated as a buy by the broker Morgans with a price target of $1.94.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended VOLPARA FPO NZ. The Motley Fool Australia has positions in and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended REA Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

happy investor, share price rise, increase, up
Growth Shares

Here’s why brokers rate these ASX growth shares as buys

Here's why these growth shares could be buys next week...

Read more »

Woman smashes dollar sign for dividend share investment
Growth Shares

2 beaten down ASX shares named as buys by experts

Here are two beaten down shares that could be buys...

Read more »

smiling man holding phone technology
Growth Shares

Analysts name 2 excellent ASX shares to buy and hold

These ASX shares could be top buy and hold options...

Read more »

The hands of three people are cupped around soil holding three small seedling plants that are grouped together in the centre of the shot with the arms of the people extending into the edges of the picture representing ASX growth shares and it being a good time to buy for future gains
Opinions

Why I think these 2 ASX shares are ideal for growth investors

This current volatile period could be a great time to go hunting for compelling businesses with strong growth potential.

Read more »

happy investor, share price rise, increase, up
Growth Shares

Here’s where I’d invest $3,000 into ASX growth shares today

Some ASX growth shares are looking really good value, in my opinion.

Read more »

An ASX shares broker analysing a chart tracking the A2 Milk share price
Growth Shares

Analysts name 2 top ASX 200 shares to buy today

Here are a couple of top ASX 200 shares that experts rate highly...

Read more »

chart showing an increasing share price
Growth Shares

Experts have named these top growth shares as buys

These growth shares are highly rated...

Read more »

A hand holding a graph trending up, indicating a surging share price on the ASX
Growth Shares

Goldman Sachs names 2 mid cap ASX shares to buy

Here are two mid cap shares that could be buys...

Read more »